# Michelle Gallaher
قسمت های برتر پادکست
به روز شده:
Top podcast episodes featuring michelle gallaher.
Under the microscope: Weekly Wrap Week Ending 13 December 2019
Morgans Senior Analyst Scott Power, and Research Analyst Iain Wilkie close the week with another episode of Under the microscope, the last on PODCAST for 2019. In this episode, the boys comment on key movements in the healthcare space and highlight a recent institutional placement in 1st Group (ASX…
Under the microscope: Opyl (ASX:OPL) - Michelle Gallaher, Chief Executive Officer
Michelle Gallaher CEO of Opyl (ASX:OPL) explains how the company is positioning itself to growth in the digital healthcare sector.
Under the microscope: ShareRoot (ASX:SRO) - Michelle Gallagher, Chief Executive Officer
ShareRoot's CEO Michelle Gallaher provides an update on the turnaround of the business to the Morgans network.
Left a $220k corporate biotech job to start a business in 2014 aged 48, with a massive mortgage. Business partner got sick, never returned so sold for $1m to a listed company. Office across from her kids' school. 2 FTE to 6 (Michelle Gallaher)
In this episode, I interview Michelle Gallaher, a Melbourne-based award-winning entrepreneur, speaker, and advocate for the Australian health technology sector and for women in science, technology, engineering maths, and medicine (STEMM). As CEO of Opyl Ltd (ASX:OPL), a company working at the inter…
Under The Microscope: ShareRoot (ASX:SRO): Michelle Gallaher, Chief Executive Officer
Michelle Gallaher CEO of ShareRoot (ASX:SRO) provides a comprehensive update on this digital healthcare company to the Morgans network.
Under the microscope: ShareRoot (ASX:SRO) Michelle Gallagher, Chief Executive Officer
ShareRoot's CEO Michelle Gallaher provides an update on the turnaround of the business to the Morgans network.
281 - ANDHealth Summit 2022 - Technology as Therapy Feature
Digital Therapeutics can potentially replace traditional therapies in healthcare like medicine, but there’s a long way to go until we see these used widely in mainstream medicine. In this podcast episode, hear from speakers who participated in the ANDHealth
Mentioned in this episode:
Sign Up to th…
292 - Improving clinical trials with AI. Michelle Gallaher, Opyl
Have you ever wondered how clinical trials have changed over time? In this episode, you will discover how artificial intelligence is used in clinical trials, specifically in participant recruitment and protocol design.
Mentioned in this episode:
Sign Up to the Free Talking Healthtech Newsletter
Sig…
In conversation with Michelle Gallaher, Founder of Opyl Ltd, TrialKey & Opin.ai
In this captivating episode of Books to the Boardroom, we dive into the remarkable journey of Michelle Gallaher, a digital health entrepreneur, speaker, advocate, and the visionary founder of Opyl Ltd, TrialKey, and Opin.ai. With a deep-rooted passion for AI and data science, Michelle is a robust l…
E37. From Discovery to Start-ups, to Scale-ups, to Patients: Innovation and Leadership with Michelle Gallaher
Michelle Gallaher is an award-winning health technology entrepreneur with a particular interest in artificial intelligence, clinical trials and ethics. Recently commencing as the inaugural CEO of Cerulea Clinical Trials, Michelle’s current focus is on building a world-leading ophthalmic clinical tr…
موتور جستجوی پادکست
می توانید از وب سایت ما برای جستجوی پادکست های3,822,989و قسمت های195,624,381بر اساس افراد، مکان ها یا موضوعات استفاده کنید.
سرمایه‌گذاری روی دانش بیشترین بازده را دارد؛ پس پادکست گوش می‌دهم.
‐ Benjamin "Llamacorn" Franklin
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
